, World Health Organization (WHO), 2019.

B. Guy, From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine, Vac, vol.29, issue.42, pp.7229-7241, 2011.

Y. S. Cho, Inhibition of acetylcholinesterase by gallic acid-graftedchitosans, Carbohydr. Polym, vol.84, issue.1, pp.690-693, 2011.

S. A. Patil, R. Patil, and S. A. Patil, Recent developments in biological activities of indanones, Eur. J. Med. Chem, vol.138, pp.182-198, 2017.

H. O. Saxena, Gallic acid-based indanone derivatives as anticancer agents, Bioorg. Med. Chem. Lett, vol.18, issue.14, pp.3914-3918, 2008.

M. S. Nel, 2-heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase, Bioorg. Chem, vol.69, pp.20-28, 2016.

H. D. Janse-van-rensburg, Methoxy substituted 2-benzylidene-1-indanone derivatives as A1 and/or A2A AR antagonists for the potential treatment of neurological conditions, MedChemComm, vol.10, issue.2, pp.300-309, 2019.

S. Xiao, Design, synthesis, and structure-activity relationships of 2-benzylidene-1-indanone derivatives as anti-inflammatory agents for treatment of acute lung injury. Drug Des, Dev. Ther, vol.12, pp.887-899, 2018.

A. T. Nielsen and W. J. Houlihan, The aldol condensation, 2011.

G. M. Morris, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility, J. Comp. Sci, vol.30, issue.16, pp.2785-2791, 2009.

M. Sabri, M. S. Oo, C. W. Yam, and M. F. , Synthesis, characterization and vasolidation properties of indanone-based chalcones, J. Phys. Sci, vol.29, issue.1, pp.99-106, 2018.

J. Coates, Interpretation of infrared spectra: A practical approach, pp.1-23, 2007.

N. Wachter, Using NMR to investigate products of aldol reactions: Identifying aldol addition versus condensation products or conjugate addition products from crossed aldol reactions of aromatic aldehydes and ketones, ACS Symp. Ser, vol.1128, pp.91-102, 2013.

R. Othman, Docking of noncompetitive inhibitors into dengue virus Type 2 protease: Understanding the interactions with allosteric binding sites, J. Chem. Inf. Model, vol.48, issue.8, pp.1582-1591, 2008.

C. F. Arias, F. Preugschat, and J. H. Strauss, Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain, Virol, vol.193, issue.2, pp.888-899, 1993.

F. Preugschat, C. W. Yao, and J. H. Strauss, In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3, J. Virol, vol.64, issue.9, pp.4364-4374, 1990.

A. Cahour, B. Falgout, and C. J. Lai, Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease, J. Virol, vol.66, issue.3, pp.1535-1542, 1992.

B. Falgout, Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins, J. Virol, vol.65, issue.5, pp.2467-2475, 1991.

K. Wilchapong, S. Pianwanit, and W. Sippl, Homology modeling and molecular dynamics simulations of dengue virus NS2B/NS3 protease: Insight into molecular interaction, J. Mol. Recog, vol.23, pp.283-300, 2010.

C. G. Noble, Ligand-bound structures of the dengue virus protease reveal the active conformation, J. Virol, vol.86, issue.1, pp.438-446, 2012.

D. Li, Strength of hydrogen bond network takes crucial roles in the dissociation process of inhibitors from the hiv-1 protease binding pocket, PLoS ONE, vol.6, issue.4, 2011.